Tay KJ - Search Results

1

Defining prostate cancer size and treatment margin for focal therapy: does intralesional heterogeneity impact the performance of multiparametric MRI?

Aslim EJ, Law YXT, Fook-Chong SMC, Ho HSS, Yuen JSP, Lau WKO, Lee LS, Cheng CWS, Ngo NT, Law YM, Tay KJ. Aslim EJ, et al. Among authors: tay kj. BJU Int. 2021 Aug;128(2):178-186. doi: 10.1111/bju.15355. Epub 2021 Mar 15. BJU Int. 2021. PMID: 33539650 Free PMC article.

2

Defining the Incremental Utility of Prostate Multiparametric Magnetic Resonance Imaging at Standard and Specialized Read in Predicting Extracapsular Extension of Prostate Cancer.

Tay KJ, Gupta RT, Brown AF, Silverman RK, Polascik TJ. Tay KJ, et al. Eur Urol. 2016 Aug;70(2):211-3. doi: 10.1016/j.eururo.2015.10.041. Epub 2015 Nov 6. Eur Urol. 2016. PMID: 26553331

3

Does mpMRI improve clinical criteria in selecting men with prostate cancer for active surveillance?

Tay KJ, Gupta RT, Holtz J, Silverman RK, Tsivian E, Schulman A, Moul JW, Polascik TJ. Tay KJ, et al. Prostate Cancer Prostatic Dis. 2017 Sep;20(3):323-327. doi: 10.1038/pcan.2017.20. Epub 2017 Apr 25. Prostate Cancer Prostatic Dis. 2017. PMID: 28440322

4

New advances in focal therapy for early stage prostate cancer.

Tay KJ, Schulman AA, Sze C, Tsivian E, Polascik TJ. Tay KJ, et al. Expert Rev Anticancer Ther. 2017 Aug;17(8):737-743. doi: 10.1080/14737140.2017.1345630. Epub 2017 Jun 28. Expert Rev Anticancer Ther. 2017. PMID: 28635336 Review.

5

Focal Therapy for Prostate Cancer with In-Bore MR-guided Focused Ultrasound: Two-Year Follow-up of a Phase I Trial-Complications and Functional Outcomes.

Tay KJ, Cheng CWS, Lau WKO, Khoo J, Thng CH, Kwek JW. Tay KJ, et al. Radiology. 2017 Nov;285(2):620-628. doi: 10.1148/radiol.2017161650. Epub 2017 Jun 26. Radiology. 2017. PMID: 28654336 Clinical Trial.

6

Erythematous Velvety Plaque of the Scrotum and Penis.

Law YXT, Gan VHL, Tay KJ. Law YXT, et al. Among authors: tay kj. JAMA Oncol. 2018 Jun 1;4(6):861-862. doi: 10.1001/jamaoncol.2017.4064. JAMA Oncol. 2018. PMID: 29270606 Review. No abstract available.

7

Surveillance after prostate focal therapy.

Tay KJ, Amin MB, Ghai S, Jimenez RE, Kench JG, Klotz L, Montironi R, Muto S, Rastinehad AR, Turkbey B, Villers A, Polascik TJ. Tay KJ, et al. World J Urol. 2019 Mar;37(3):397-407. doi: 10.1007/s00345-018-2363-y. Epub 2018 Jun 9. World J Urol. 2019. PMID: 29948045 Review.

8

Outcomes of combination MRI-targeted and transperineal template biopsy in restaging low-risk prostate cancer for active surveillance.

Chen K, Tay KJ, Law YM, Aydin H, Ho H, Cheng C, Yuen JSP. Chen K, et al. Among authors: tay kj. Asian J Urol. 2018 Jul;5(3):184-193. doi: 10.1016/j.ajur.2017.07.001. Epub 2017 Jul 12. Asian J Urol. 2018. PMID: 29988897 Free PMC article.

9

Prostate focal therapy: the rule or exception?

Tay KJ. Tay KJ. Curr Opin Urol. 2018 Nov;28(6):512-521. doi: 10.1097/MOU.0000000000000540. Curr Opin Urol. 2018. PMID: 30124517

10

Evolving trends in the surgical management of renal masses over the past two decades: A contemporary picture from a large prospectively-maintained database.

Chen K, Lee A, Huang HH, Tay KJ, Sim A, Lee LS, Cheng CWS, Ng LG, Ho HSS, Yuen JSP. Chen K, et al. Among authors: tay kj. Int J Urol. 2019 Apr;26(4):465-474. doi: 10.1111/iju.13909. Epub 2019 Feb 28. Int J Urol. 2019. PMID: 30818418

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters